Ntisense Oligonukleotide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ntisense oligonukleotide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ntisense Oligonukleotide Today - Breaking & Trending Today

64 Millionen Euro zur Entwicklung RNA-basierter Therapien gegen Herzerkrankungen

Cardior Pharmaceuticals hat eine Serie-B-Finanzierung in Höhe von 64 Millionen Euro (USD 76 Millionen) abgeschlossen. Lead-Investor ist Inkef Capital, neue Co-Investoren sind Fund+, Sunstone, Hade . ....

Thomas Thum , University Hanover , Research Of Prof , Bristol Myers Squibb , Development Of Cdr , Company In Ascenions , Cardior Pharmaceuticals , Euros For , Rna Basierter Therapies , New Co Investoren , Hadean Ventures , Its Active Ingredient , Disease Will , Medical University Hanover , Cardior Opens , Research Thrown , Serieb Finanzierung , Herz Kreislauf Erkrankungen , Rna Therapeutika , Ntisense Oligonukleotide ,